2 Einträge von mit group norbert
www.sipbb.ch
Datum der Indexierung 04.10.2024 19:40:26
erkannte Namen Norbert Gemmeke | Daniel Arn | Hans Christen | Sebastian Wörwag | Hans Gattlen | Denis Grisel | Félix Kunz | Kunz Chairman |
weitere Namen in www.sipbb.ch 8
Subdomain:
extern (outbound) Link/Domain 9 in www.sipbb.ch
intern (inbound) Link/Domain www.sipbb.ch
Alle Links in alle Links in www.sipbb.ch
Kombination Keywords park sites | administration vous | conseil site | switzerland-innovation.com notre | swiss switzerland | sipbb obtenez | biel/bienne hans | contact managing | center innovation | newsletter group |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Group & EquityNova AG Denis Grisel Partenaire F&P Group Félix Kunz Chairman BOD and Managing Partner SIPBB (ad. interim) OBTENEZ VOTRE NEWSLETTER PERSONNALISÉE S’ENREGISTRER FACEBOOK Linkedin Youtube Instagram Contact Switzerland Innovation Park Biel Norbert Gemmeke Managing Director bei HARTING Electric GmbH & Co.KG Hanover Daniel Arn CEO Hans Christen AG Prof. Dr. Sebastian Wörwag Rektor Berner Fachhochschule Hans Gattlen VR-Präsident SwissFactory / Group & EquityNova AG Den
Text Inhalt Text aus URL
Log Metriken 10363
erkannte Namen Norbert Gemmeke | Daniel Arn | Hans Christen | Sebastian Wörwag | Hans Gattlen | Denis Grisel | Félix Kunz | Kunz Chairman |
weitere Namen in www.sipbb.ch 8
Subdomain:
extern (outbound) Link/Domain 9 in www.sipbb.ch
intern (inbound) Link/Domain www.sipbb.ch
Alle Links in alle Links in www.sipbb.ch
Kombination Keywords park sites | administration vous | conseil site | switzerland-innovation.com notre | swiss switzerland | sipbb obtenez | biel/bienne hans | contact managing | center innovation | newsletter group |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Group & EquityNova AG Denis Grisel Partenaire F&P Group Félix Kunz Chairman BOD and Managing Partner SIPBB (ad. interim) OBTENEZ VOTRE NEWSLETTER PERSONNALISÉE S’ENREGISTRER FACEBOOK Linkedin Youtube Instagram Contact Switzerland Innovation Park Biel Norbert Gemmeke Managing Director bei HARTING Electric GmbH & Co.KG Hanover Daniel Arn CEO Hans Christen AG Prof. Dr. Sebastian Wörwag Rektor Berner Fachhochschule Hans Gattlen VR-Präsident SwissFactory / Group & EquityNova AG Den
Text Inhalt Text aus URL
Log Metriken 10363
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:30:14
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Group Our Story Diversity, Equity & Inclusion Bern Location Partnering Cooperation More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma. Learn More R&D Switzerland at a glance: We ar Norbert Heimberger. During his time at the Behring plants, Dr Heimberger discovered a new method of pasteurizing plasma proteins. 2007 FDA approval for Rhophylac® for ITP in the U.S. The U.S. Food and Drug Administration approves
Text Inhalt Text aus URL
Log Metriken 86083
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Group Our Story Diversity, Equity & Inclusion Bern Location Partnering Cooperation More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma. Learn More R&D Switzerland at a glance: We ar Norbert Heimberger. During his time at the Behring plants, Dr Heimberger discovered a new method of pasteurizing plasma proteins. 2007 FDA approval for Rhophylac® for ITP in the U.S. The U.S. Food and Drug Administration approves
Text Inhalt Text aus URL
Log Metriken 86083